LAZARD ASSET MANAGEMENT LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 121 filers reported holding TRANSMEDICS GROUP INC in Q2 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$4,036
+9072.7%
73,722
+13809.8%
0.01%
Q2 2023$44
+10.0%
5300.0%0.00%
Q1 2023$40
-99.9%
530
-53.2%
0.00%
Q3 2021$37,000
+12.1%
1,133
+42.2%
0.00%
Q1 2021$33,0007970.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q2 2021
NameSharesValueWeighting ↓
Roubaix Capital, LLC 264,438$5,027,0004.84%
Abrams Capital Management 3,499,859$66,532,0002.07%
Sandhill Capital Partners LLC 736,175$13,995,0001.55%
EMERALD ADVISERS, LLC 451,542$8,584,0000.36%
RTW INVESTMENTS, LP 503,266$9,567,0000.36%
EMERALD MUTUAL FUND ADVISERS TRUST 429,868$8,172,0000.33%
NEXT CENTURY GROWTH INVESTORS LLC 107,045$2,034,0000.26%
ELEMENT CAPITAL MANAGEMENT LLC 63,175$1,201,0000.26%
HAMILTON LANE ADVISORS LLC 19,364$368,0000.16%
Harbour Capital Advisors, LLC 20,900$397,0000.15%
View complete list of TRANSMEDICS GROUP INC shareholders